TY - JOUR
T1 - Fasting blood triglycerides vary with circadian phase in both young and older people
AU - Yuan, Robin K.
AU - Zitting, Kirsi Marja
AU - Wang, Wei
AU - Buxton, Orfeu M.
AU - Williams, Jonathan S.
AU - Duffy, Jeanne F.
AU - Czeisler, Charles A.
N1 - Funding Information:
This study was supported by NIA P01 AG009975 and was conducted at the BWH Center for Clinical Investigation (CCI), part of Harvard Catalyst (Harvard Clinical and Translational Science Center) supported by NIH UL1 TR001102, BWH, and Harvard University and its affiliated academic health care centers. RKY was supported by T32HL007901 and F32HL143893. KMZ was supported in part by a fellowship from the Finnish Cultural Foundation. WW, JSW, and JFD report no conflict of interest. Outside the current work, OMB received subcontract grants to Penn State from Mobile Sleep Technologies (NSF/STTR #1622766, NIH/NIA SBIR R43AG056250), receives honoraria and travel support for Continuing Dental Education lectures at Tufts School of Dental Medicine, received honoraria and travel support for speaking at Boston College, Boston University and Allstate, received an honorarium for speaking for Allstate, and receives an honorarium for his role as Editor‐in‐chief (designate) of Sleep Health sleephealthjournal.org. CAC reports grants from Cephalon Inc., Jazz Pharmaceuticals Plc., Inc., National Football League Charities, Optum, Philips Respironics, Inc., Regeneron Pharmaceuticals, ResMed Foundation, San Francisco Bar Pilots, Sanofi S.A., Sanofi‐Aventis, Inc, Schneider Inc., Sepracor, Inc, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, Sysco, Takeda Pharmaceuticals, Teva Pharmaceuticals Industries, Ltd., and Wake Up Narcolepsy; and personal fees from Bose Corporation, Boston Celtics, Boston Red Sox, Cephalon, Inc., Columbia River Bar Pilots, Ganésco Inc., Institute of Digital Media and Child Development, Klarman Family Foundation, Samsung Electronics, Quest Diagnostics, Inc., Teva Pharma Australia, Vanda Pharmaceuticals, Washington State Board of Pilotage Commissioners, Zurich Insurance Company, Ltd. In addition, CAC holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker) and holds an equity interest in Vanda Pharmaceuticals, Inc. Since 1985, CAC has also served as an expert on various legal and technical cases related to sleep and/or circadian rhythms, including those involving the following commercial entities: Casper Sleep Inc., Comair/Delta Airlines, Complete General Construction Company, FedEx, Greyhound, HG Energy LLC, Purdue Pharma, LP, South Carolina Central Railroad Co., Steel Warehouse Inc., Stric‐Lan Companies LLC, Texas Premier Resource LLC, and United Parcel Service (UPS). CAC receives royalties from the New England Journal of Medicine; McGraw Hill; Houghton Mifflin Harcourt/Penguin; and Philips Respironics, Inc. for the Actiwatch‐2 and Actiwatch‐Spectrum devices. CAC’s interests were reviewed and managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.
Publisher Copyright:
© 2020 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Daily rhythms in several physiological processes are important for cardiometabolic health. The lipid panel is used clinically to assess cardiovascular disease risk, but previous attempts to demonstrate circadian variation in lipids have failed to uncouple the endogenous circadian rhythm from the effects of meals and wake duration. Changes in basal lipid levels and dampening of circadian rhythms have been reported with aging, but it is unknown whether aging is also associated with changes in the rhythmic variation of lipids. We measured fasting lipid panels (triglycerides, total cholesterol, high-density lipoprotein, and low-density lipoprotein) in blood at wake time in 21 healthy adults using a specialized laboratory protocol that uncouples sleep–wake and activity-related effects from the endogenous circadian rhythm. Young and older adults exhibited endogenous circadian variations in fasting triglycerides, with both groups peaking in the early biological morning. Young adults also exhibited significant circadian rhythmicity in total cholesterol and low-density lipoprotein, while older adults did not exhibit circadian rhythmicity in any other lipids. These results reveal that triglyceride metabolism may be regulated by the central circadian pacemaker. Moreover, our findings may have clinical implications in assessing cardiovascular risk in shift workers and younger adults, since routine measurement of morning/fasting lipids may not fully and reliably assess triglyceride- and other lipid-related biomarkers of cardiovascular disease risk in these groups.
AB - Daily rhythms in several physiological processes are important for cardiometabolic health. The lipid panel is used clinically to assess cardiovascular disease risk, but previous attempts to demonstrate circadian variation in lipids have failed to uncouple the endogenous circadian rhythm from the effects of meals and wake duration. Changes in basal lipid levels and dampening of circadian rhythms have been reported with aging, but it is unknown whether aging is also associated with changes in the rhythmic variation of lipids. We measured fasting lipid panels (triglycerides, total cholesterol, high-density lipoprotein, and low-density lipoprotein) in blood at wake time in 21 healthy adults using a specialized laboratory protocol that uncouples sleep–wake and activity-related effects from the endogenous circadian rhythm. Young and older adults exhibited endogenous circadian variations in fasting triglycerides, with both groups peaking in the early biological morning. Young adults also exhibited significant circadian rhythmicity in total cholesterol and low-density lipoprotein, while older adults did not exhibit circadian rhythmicity in any other lipids. These results reveal that triglyceride metabolism may be regulated by the central circadian pacemaker. Moreover, our findings may have clinical implications in assessing cardiovascular risk in shift workers and younger adults, since routine measurement of morning/fasting lipids may not fully and reliably assess triglyceride- and other lipid-related biomarkers of cardiovascular disease risk in these groups.
UR - http://www.scopus.com/inward/record.url?scp=85086354097&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086354097&partnerID=8YFLogxK
U2 - 10.14814/phy2.14453
DO - 10.14814/phy2.14453
M3 - Article
C2 - 32519460
AN - SCOPUS:85086354097
SN - 2051-817X
VL - 8
JO - Physiological reports
JF - Physiological reports
IS - 11
M1 - e14453
ER -